VIVENT HEALTH, INC.

概览

试验阶段分布

暂无试验阶段数据

试验状态分布

暂无试验数据

药物批准

暂无批准数据

资讯

American Red Cross Declares Emergency Blood Shortage as Supply Drops to Crisis Levels

- The American Red Cross has declared an emergency blood shortage, with the national blood supply falling to just 25% of what is needed, marking only the second such crisis declaration in its history. - Type O positive blood reserves have dropped to less than a one-day supply, forcing the organization to limit hospital distributions to only the most critical, life-threatening emergencies. - Summer trauma cases, including a 65% increase in fireworks-related injuries at one major medical center, are driving demand while donations decline due to school closures, vacations, and extreme weather. - The Red Cross estimates that just three additional donors at each blood drive this summer could help stabilize the national blood supply.

Jul 14, 2026

TRACTION Trial Shows Tranexamic Acid Reduces Blood Transfusions by 31% in Non-Cardiac Surgery Without Increasing Clot Risk

- The TRACTION trial demonstrated that tranexamic acid reduced the need for red blood cell transfusions by 31% in patients undergoing high-risk non-cardiac surgeries compared to placebo. - Among 8,273 patients across 10 Canadian hospitals, tranexamic acid lowered transfusion rates from 9.8% to 7.4% without increasing venous thromboembolism risk. - The findings suggest broad implementation could prevent 5-10 million units of perioperative red cell transfusions annually in the estimated 100 million non-cardiac surgeries performed yearly. - The inexpensive, widely available drug showed particular safety in cancer patients, who comprised 60.5% of the study population and face elevated thrombosis risk.

Dec 9, 2025